Innate Immune Recognition of EBV

Area of Science:

• Immunology
• Virology
• Oncology

Background:

• Epstein-Barr virus (EBV) infects approximately 95% of the global population.
• EBV infection is usually asymptomatic in childhood but can cause infectious mononucleosis (IM) in adolescents and adults.
• The innate immune system, including pattern recognition receptors (PRRs), is vital for controlling EBV.

Purpose of the Study:

• To review the innate immune recognition of Epstein-Barr virus (EBV).
• To discuss the role of PRRs in detecting viral pathogen-associated molecular patterns (PAMPs).
• To explore the link between EBV, innate immunity, and associated diseases like cancer.

Main Methods:

• This review synthesizes current research on innate immune responses to EBV.
• It examines the function of pattern recognition receptors (PRRs) in identifying viral components.
• The discussion includes immune cells like macrophages, dendritic cells, NK cells, and B cells.

Main Results:

• PRRs on various immune and non-immune cells detect EBV PAMPs, initiating the innate immune response.
• Effective innate immunity is critical for preventing EBV-induced cell transformation and malignancy.
• However, excessive or prolonged innate immune responses can promote chronic inflammation and increase cancer risk.

Conclusions:

• Innate immune recognition of EBV is a complex process with implications for disease.
• Understanding EBV-PRR interactions is key to managing EBV-associated conditions.
• Balancing innate immunity is essential to prevent both uncontrolled viral spread and chronic inflammation-driven pathologies.